Skip to main content
Clinical Trials/IRCT20210324050760N1
IRCT20210324050760N1
Not yet recruiting
Phase 4

Evaluation of clinical course and disease consequences with or without Remdesivir intake in patients with COVID-19 infection

Shahre-kord University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahre-kord University of Medical Sciences
Enrollment
100
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Shahre-kord University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Blood oxygen saturation\<93% in room air or patients with patients in need of supportive oxygen or ventilation or
  • Patients with pulmonary infiltration in radiological studies

Exclusion Criteria

  • Alanine aminotransferase and Aspartate aminotransferase rising more than 5 times the upper limit of normal
  • Glomerular filtration rate less than 30ml/minute(according to Cockroft\-Gault formula)

Outcomes

Primary Outcomes

Not specified

Similar Trials